Overview

Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

Status:
Completed

Trial end date:
1990-06-01

Target enrollment:

Participant gender:

Summary

To determine if surfactant administration at birth in infants at high risk for respiratory distress syndrome (RDS) modified the clinical course of the syndrome.

Phase:

Phase 3

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Pulmonary Surfactants